Menasu

Fentanyl, the active ingredient in Menasu, is an opioid analgesic presented as a sublingual formulation for sublingual use. It delivers rapid, high‑potency analgesia and is employed when intense pain requires swift relief, especially in patients already maintained on opioid regimens for chronic cancer‑related pain.

GNH USA supplies Menasu as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to this controlled‑substance formulation for qualified healthcare providers in compliance with EU regulations and quality standards.

Fentanyl is an opioid analgesic used primarily for severe pain management in specific clinical situations.

Breakthrough cancer pain: provides rapid relief for episodic pain spikes in patients on stable opioid therapy. Post‑operative pain: used when intense pain persists despite standard analgesics after surgery. Severe chronic non‑cancer pain: considered when other opioids are insufficient to control pain.

Fentanyl may cause a range of adverse reactions, varying from mild to potentially life‑threatening.

Common Side Effects: - Nausea: feeling of sickness or urge to vomit. - Constipation: reduced bowel movements. - Dizziness: light‑headed sensation. - Sedation: increased sleepiness.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be fatal. - Severe hypotension: marked drop in blood pressure. - Chest wall rigidity: muscle stiffness that can impair breathing.

When prescribing or handling Menasu, several safety considerations should be observed to minimize risk.

Patient assessment: evaluate opioid tolerance and pain severity before initiating therapy. Concomitant CNS depressants: avoid or use with caution when combined with benzodiazepines or alcohol. Respiratory monitoring: closely watch breathing, especially during dose titration or in opioid‑naïve patients. Pregnancy and lactation: contraindicated unless benefits outweigh risks; consult specialist. Education: instruct patients on proper sublingual placement and to keep medication out of reach of children. Store at below 25°C: keep in original container, protect from moisture and light.

Fentanyl can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Other opioids: additive respiratory depression and sedation. - Benzodiazepines or barbiturates: heightened CNS depression risk. - MAO inhibitors: may cause severe hypotension or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): increase fentanyl plasma levels. - CYP3A4 inducers (e.g., rifampin, carbamazepine): reduce fentanyl effectiveness.